OSR Holdings Faces Nasdaq Compliance Challenge Amid Notable Trading Volatility

OSR Holdings, Inc., traded under the Nasdaq symbol OSRH, recently disclosed that it received a notification from The Nasdaq Stock Market LLC regarding its compliance with listing regulations. On September 5, 2025, the company was informed that it did not meet Nasdaq Listing Rule 5550(a)(2), which mandates a minimum bid price of $1.00 per share for listed securities. Despite this setback, OSR Holdings assured investors that its stock would continue to be traded on the Nasdaq Capital Market. The company has until March 4, 2026, to remedy this deficiency.

In light of the recent fluctuation in share prices, OSR Holdings articulated confidence that these prices do not accurately reflect the underlying strength and potential of its business operations. The organization is steadfast in its commitment to advancing pivotal therapeutic programs, particularly in areas like oral immunotherapies and regenerative medicine. Furthermore, it is reinforcing its financial adaptability through its Digital Asset Treasury (DAT) strategy.

In addition to these innovative strategies, OSR Holdings has been assessing Woori IO, a company specializing in non-invasive glucose monitoring technology. This alignment reinforces OSR’s dedication to pioneering impactful healthcare innovations.

The firm has also taken note of irregular trading patterns surrounding its stocks. Recent analysis of publicly available SEC data has unveiled significant discrepancies in settlement volumes during periods characterized by high trading volatility, extensive trading volumes, or critical press releases. Such data has led the company to suspect potential manipulative short selling tactics that could be exerting undue pressure on their stock price.

Peter Hwang, CEO of OSR Holdings, emphasized the corporation's commitment to operational execution while concurrently addressing these unusual trading dynamics. “Our focus remains firmly on advancing our scientific programs and creating long-term value for our stakeholders,” he stated. “We take market integrity very seriously and will engage in necessary actions to counteract these irregular trading activities.”

OSR Holdings is devoted to maintaining the integrity of its market operations. The company's plans include closely monitoring trading activities and collaborating with regulatory bodies to explore various options that would uphold a fair trading environment for its securities.

Tim Smith, head of Global Investor Relations at OSR Holdings, remarked, “OSR Holdings is anchored by solid scientific foundations and a diverse array of innovations. Our digital asset treasury strategies exemplify our forward-thinking vision.” He ensured that the company remains committed to navigating these challenges effectively while prioritizing the advancement of potentially transformative healthcare programs.

About OSR Holdings

OSR Holdings, Inc. is a global healthcare holding company centered around advancing biomedical innovations aimed at enhancing health and wellness. Through its various subsidiaries, OSR Holdings is active in the realms of immuno-oncology, regenerative biologics, and the distribution of medical devices. The company’s vision is to expand a portfolio of innovative healthcare and wellness entities to improve patient care through cutting-edge research and development.

For more information, the company invites interested parties to visit www.OSR-Holdings.com.